Growth rate-corrected (GR) dose-response metric signatures across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 3 of 4: Median, upper quartile, and lower quartile GR metrics per perturbagen. - Dataset (ID:20270)

Small Molecules Studied

HMS LINCS ID Name Alternative Names LINCS ID Structure Image PubChem CID
10099-2 Nilotinib
AMN-107
LSM-1099 644241
10108-2 Geldanamycin LSM-42789 644250
10280-1 Triciribine LSM-3810 65399
10260-1 Ispinesib
SB-715992
LSM-5732 6851740
10257-1 GSK923295 LSM-4278 68651179
10048-7 PD184352
CI-1040
LSM-1048 6918454
10048-6 PD184352
CI-1040
LSM-1048 6918454
10048 PD184352
CI-1040
LSM-1048 6918454
10251-1 Fascaplysin LSM-4272 73293
10208-2 JNK-IN-5A
TCS JNK 5a; KIN001-188
LSM-1209 766949
10228-2 IKK16 LSM-2309 9549298
10348-1 Z-Leu-Leu-Norvalinal
MG-115
LSM-6358 9868928
10274-1 SB-3CT LSM-4293 9883002
10136-2 TPCA-1 LSM-1136 9903786
10096-2 ZM-447439 LSM-1096 9914412
10514-1 PS-1145 9949093
10262-1 L-779450 LSM-4283 9950176
10253-1 Glycyl-H-1152 LSM-4274
10279-1 Trichostatin A LSM-43005
10245-1 Cisplatin
CDDP; cis-Diaminodichloroplatinum; Cisplatinum; Lederplatin; Briplatin; Cismaplat
LSM-4268